Why the study?
The study was conducted to explore the association between the degree of coronary artery calcium and the progression of calcific aortic valve disease.
Does a higher coronary artery calcium score predict the echocardiographic progression of calcific aortic valve disease in patients undergoing CCTA?
Does a higher coronary artery calcium score predict the echocardiographic progression of calcific aortic valve disease in patients undergoing CCTA?
Severe coronary artery calcification (CAC ≥400) is strongly associated with the subsequent echocardiographic progression of calcific aortic valve disease, suggesting that extensive coronary calcium may help identify patients at higher risk for advancing aortic stenosis.
Answers are grounded in this paper and cite their sources.
High CAC was associated with AS progression in this cohort; leaves open whether CAC informs surveillance or warrants prospective trials.
OBJECTIVES: To explore the association between the degree of coronary artery calcium (CAC) and the progression of calcific aortic valve disease (CAVD). DESIGN: A single-centre retrospective cohort study using a hospital-based database. PARTICIPANTS: A total of 2898 patients who underwent coronary CT angiography and serial echocardiograms at ≥6 months apart were included. Initial echocardiography was performed within 6 months from the time of CCTA. OUTCOME MEASURES: CAC was divided into four groups: 0, 1-99, 100-399 and ≥400 (Agatston units, AU). The progression of CAVD was defined in two ways: progression 1 as at least one grade of progression, progression 2 as at least moderate aortic stenosis (AS) at follow-up. RESULTS: At the initial CAVD grade, patients with at least mild AS tended to increase with increasing CAC (p<0.001). During a median follow-up of 3.2 years (IQR, 1.8-5.0 years), 101 patients (3.5%) experienced progression 1 and 24 patients (0.8%) suffered progression 2. There was a statistically significant increase in risk of progression 1 in CAC 100-399 and ≥400 groups than CAC 0 and 1-99 groups (p<0.001). In progression 2, the CAC≥400 group showed a higher progression rate than the other groups (p<0.001). In multivariable logistic regression, age (adjusted OR (aOR), 1.06; 95% CI, 1.02 to 1.09; p=0.001), CAC≥400 (aOR, 2.55 vs CAC 0 as a reference group; 95% CI, 1.19 to 5.46; p=0.016), body mass index (aOR, 1.09; 95% CI, 1.02 to 1.17; p=0.010) and initial peak aortic jet velocity (aOR, 1.21 per 0.1 m/s increase; 95% CI, 1.14 to 1.28; p<0.001) were associated with progression 1. In progression 2, CAC≥400 (aOR, 44.5 vs CAC 0 as a reference group; 95% CI, 1.09 to 1810; p=0.045), eGFR (aOR, 0.88; 95% CI, 0.80 to 0.97; p=0.007), left ventricular mass index (aOR, 1.05; 95% CI, 1.01 to 1.10; p=0.029) and initial peak aortic jet velocity (aOR, 4.21 per 0.1 m/s increase; 95% CI, 1.86 to 9.53; p=0.001) were significant determinants. CONCLUSIONS: CAC was significantly associated with the progression of CAVD. Particularly, CAC≥400 was linked to progression toward significant AS.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: